English
Spanish
Gujarati
Hindi
Marathi
Tamil
Russian
Chinese (Simplified)
Chinese (Traditional)
Korean
Phase One is the beginning of human trials, it has about 20-100 participants in it. There are 25 vaccines in phase one as of 4/25/21. Click here to go to all vaccines in development. [Updated April 25, 2021]
DNA
Inactivated
Replicating Viral Vector
- City of Hope
- Institute Pasteur/Themis/Univ. of Pittsburg Center for Vaccine Research
- Merck Sharpe and Dohme
Non-Replicated Viral Vector
RNA
Live Attenuated Virus
Protein Subunit
- Anhui Zhifei Longcom Biopharmaceutical/ Institute of Microbiology,Chinese Academy of Sciences
- Chinese Academy of Military Sciences
- Clover Biopharmaceuticals Inc./GSK/Dynavax
- Covaxx
- FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo
- Instituto Finlay de Vaccunas
- Medigen Vaccine Biologics Corporation/NIAID/Dynavax
- University Hospital Tuebingen
- University of Queensland/GSK/Dynavax
- Vaxine Pty Ltd
VLP
- N/A
Unknown
- N/A
